These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34336739)

  • 1. Cardiomyopathy in Genetic Aortic Diseases.
    Muiño-Mosquera L; De Backer J
    Front Pediatr; 2021; 9():682390. PubMed ID: 34336739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
    De Backer J
    Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmia and impaired myocardial function in heritable thoracic aortic disease: An international retrospective cohort study.
    Demolder A; Bianco L; Caruana M; Cervi E; Evangelista A; Jondeau G; Buttigieg LL; López-Sainz Á; Delmás EM; Pini A; Sabaté-Rotés A; Szöcs K; Tchitchinadze M; Teixidó-Tura G; von Kodolitsch Y; Muiño-Mosquera L; De Backer J
    Eur J Med Genet; 2022 Jun; 65(6):104503. PubMed ID: 35427808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTAD patient pathway: Strategy for diagnostic work-up of patients and families with (suspected) heritable thoracic aortic diseases (HTAD). A statement from the HTAD working group of VASCERN.
    Caruana M; Baars MJ; Bashiardes E; Benke K; Björck E; Codreanu A; de Moya Rubio E; Dumfarth J; Evangelista A; Groenink M; Kallenbach K; Kempers M; Keravnou A; Loeys B; Muiño-Mosquera L; Nagy E; Milleron O; Nistri S; Pepe G; Roos-Hesselink J; Szabolcs Z; Teixidó-Tura G; Timmermans J; Van de Laar I; van Kimmenade R; Verstraeten A; Von Kodolitsch Y; De Backer J; Jondeau G
    Eur J Med Genet; 2023 Jan; 66(1):104673. PubMed ID: 36460281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Genetic Testing in Patients with Heritable Thoracic Aortic Diseases.
    Monda E; Lioncino M; Verrillo F; Rubino M; Caiazza M; Mauriello A; Guarnaccia N; Fusco A; Cirillo A; Covino S; Altobelli I; Diana G; Palmiero G; Dongiglio F; Natale F; Cesaro A; Bossone E; Russo MG; Calabrò P; Limongelli G
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of Aortic Root Modification Associated With Bicuspid Aortic Valve in Marfan Syndrome.
    Milleron O; Ropers J; Arnoult F; Bouleti C; Delorme G; Langeois M; Tchitchinadze M; Guien C; Beroud C; Boileau C; Jondeau G
    Circ Cardiovasc Imaging; 2019 Mar; 12(3):e008129. PubMed ID: 30841707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms.
    Milewicz DM; Michael K; Fisher N; Coselli JS; Markello T; Biddinger A
    Circulation; 1996 Dec; 94(11):2708-11. PubMed ID: 8941093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Management of Adults with Marfan Syndrome.
    Isekame Y; Gati S; Aragon-Martin JA; Bastiaenen R; Kondapally Seshasai SR; Child A
    Eur Cardiol; 2016 Dec; 11(2):102-110. PubMed ID: 30310455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically Triggered Thoracic Aortic Disease: Who Should be Tested?
    Duarte VE; Yousefzai R; Singh MN
    Methodist Debakey Cardiovasc J; 2023; 19(2):24-28. PubMed ID: 36910552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Risk for Aortic Aneurysm in Adolescent Idiopathic Scoliosis.
    Haller G; Alvarado DM; Willing MC; Braverman AC; Bridwell KH; Kelly M; Lenke LG; Luhmann SJ; Gurnett CA; Dobbs MB
    J Bone Joint Surg Am; 2015 Sep; 97(17):1411-7. PubMed ID: 26333736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.
    Loeys B; Nuytinck L; Delvaux I; De Bie S; De Paepe A
    Arch Intern Med; 2001 Nov; 161(20):2447-54. PubMed ID: 11700157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiogenetics: genetic testing in the diagnosis and management of patients with aortic disease.
    Thakker PD; Braverman AC
    Heart; 2021 Apr; 107(8):619-626. PubMed ID: 33334864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing of the FBN1 gene in Chinese patients with Marfan/Marfan-like syndrome.
    Yang H; Luo M; Chen Q; Fu Y; Zhang J; Qian X; Sun X; Fan Y; Zhou Z; Chang Q
    Clin Chim Acta; 2016 Aug; 459():30-35. PubMed ID: 27234404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel fibrillin-1 gene missense mutation associated with neonatal Marfan syndrome: a case report and review of the mutation spectrum.
    Peng Q; Deng Y; Yang Y; Liu H
    BMC Pediatr; 2016 Apr; 16():60. PubMed ID: 27138491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular manifestations in Marfan syndrome and related diseases; multiple genes causing similar phenotypes.
    Cook JR; Carta L; Galatioto J; Ramirez F
    Clin Genet; 2015; 87(1):11-20. PubMed ID: 24867163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Clinical Trials of Losartan With and Without β-Blockers to Block Aneurysm Growth in Patients With Marfan Syndrome: A Review.
    Hofmann Bowman MA; Eagle KA; Milewicz DM
    JAMA Cardiol; 2019 Jul; 4(7):702-707. PubMed ID: 31066871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of a next generation sequencing panel assay for Marfan and Marfan-like syndromes featuring aortopathy.
    Wooderchak-Donahue W; VanSant-Webb C; Tvrdik T; Plant P; Lewis T; Stocks J; Raney JA; Meyers L; Berg A; Rope AF; Yetman AT; Bleyl SB; Mesley R; Bull DA; Collins RT; Ojeda MM; Roberts A; Lacro R; Woerner A; Stoler J; Bayrak-Toydemir P
    Am J Med Genet A; 2015 Aug; 167A(8):1747-57. PubMed ID: 25944730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome.
    Emrich FC; Okamura H; Dalal AR; Penov K; Merk DR; Raaz U; Hennigs JK; Chin JT; Miller MO; Pedroza AJ; Craig JK; Koyano TK; Blankenberg FG; Connolly AJ; Mohr FW; Alvira CM; Rabinovitch M; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):146-54. PubMed ID: 25359856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations.
    Faivre L; Masurel-Paulet A; Collod-Béroud G; Callewaert BL; Child AH; Stheneur C; Binquet C; Gautier E; Chevallier B; Huet F; Loeys BL; Arbustini E; Mayer K; Arslan-Kirchner M; Kiotsekoglou A; Comeglio P; Grasso M; Halliday DJ; Béroud C; Bonithon-Kopp C; Claustres M; Robinson PN; Adès L; De Backer J; Coucke P; Francke U; De Paepe A; Boileau C; Jondeau G
    Pediatrics; 2009 Jan; 123(1):391-8. PubMed ID: 19117906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.